BriaCell expands Phase 3 breast cancer study to 79 clinical sites
Tweet Send to a Friend
BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) announced the addition of three major cancer centers to its ongoing Phase ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


